“Lipofectamine-Mediated CRISPR-Cas9 Delivery Targeting the mecA Gene in Methicillin-Resistant Staphylococcus aureus: A Novel Approach to Reverse Antibiotic Resistance” (2026) Wah Academia Journal of Health and Nutrition, 2(2), pp. 27–35. doi:10.63954/bantev40.